Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 125

Venafi picks first three developers for fund

Jetstack, OpenCredo and Cygnacom are the first three recipients of cash from the cybersecurity technology producer's Machine Identity Protection Development Fund.

Dec 17, 2018

XianLife eats up corporate funding

Convenience store management software provider XianLife has raised an eight-figure sum from investors including Megvii and SBI Investment.

Dec 17, 2018

MedaPhor clues on to Parkwalk investment

Parkwalk Advisors has invested an undisclosed sum in Cardiff ultrasound simulation technology developer MedaPhor through its Opportunities Fund.

Dec 17, 2018

Xorlab gets the message in $1.9m round

ETH Zurich-founded cybersecurity business Xorlab focuses on thwarting email attacks through a combination of machine learning and advanced dynamic analysis.

Dec 17, 2018

Otsuka takes up Veryan’s acquisition offer

ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.

Dec 17, 2018

Corporate venturing deal net: 10-14 December 2018

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Dec 14, 2018

DenovoMatrix binds funding

TU Dresden spinout DenovoMatrix hopes to commercialise a method for effectively cultivating stem cell production.

Dec 14, 2018

Sensorygen bites into $50,000

Vertical Venture Partners has joined university venture fund Highlander Venture Fund as an investor in UC Riverside-founded mosquito repellent developer Sensorygen.

Dec 14, 2018

Zest Tea brews $1m

The tea product supplier has become the fourth business backed by University of Maryland Momentum Fund.

Dec 13, 2018

Istesso stakes $7.6m

IP Group has poured more funding into Istesso, whose treatment for rheumatoid arthritis traces its roots to an Aberdeen spinout, to drive immuno-metabolism therapies for autoimmune diseases.

Dec 13, 2018
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here